Back to funds
View filing
Cormorant Asset Management, LP
Updated 6 days agoManaged by Cormorant Asset Management, Lp • Latest filing Q3 2026
Portfolio value
$1.5B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $2.2B |
| Q1 2026 | $2B |
| Q2 2026 | $2B |
| Q3 2026 | $1.5B |
Top holdings
60 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $149M | 4.62M | 10.01% | — | |
| 2 | $145.6M | 500.0K | 9.78% | — | |
| 3 | $82.6M | 2.46M | 5.54% | — | |
| 4 | $75.5M | 1.86M | 5.07% | — | |
| 5 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $73.3M | 17.88M | 4.92% | — |
| 6 | $73.3M | 5.00M | 4.92% | — | |
| 7 | ? N/A BLOSSOMHILL THERAPEUTICS INC | $67.4M | 3.61M | 4.52% | — |
| 8 | $63.7M | 3.98M | 4.27% | — | |
| 9 | $44M | 500.0K | 2.96% | — | |
| 10 | $42.1M | 425.0K | 2.83% | — | |
| 11 | $39.9M | 800.0K | 2.68% | — | |
| 12 | ? N/A ELECTRA THERAPEUTICS INC | $37.9M | 3.37M | 2.54% | — |
| 13 | $33.4M | 2.86M | 2.24% | — | |
| 14 | $33.3M | 400.0K | 2.24% | — | |
| 15 | ? N/A ATTOVIA THERAPEUTICS INC | $30.7M | 1.79M | 2.06% | — |
| 16 | $30.6M | 1.03M | 2.05% | — | |
| 17 | ? N/A LATIGO BIOTHERAPEUTICS INC | $30.3M | 1.82M | 2.04% | — |
| 18 | $27.4M | 2.47M | 1.84% | — | |
| 19 | $26.6M | 5.50M | 1.79% | — | |
| 20 | ? N/A CLIMB BIO INC | $24.2M | 2.11M | 1.62% | — |